Isolation and characterization of a highly attenuated respiratory syncytial virus (RSV) vaccine candidate by mutagenesis of the incompletely attenuated RSV A2 ts-1 NG-1 mutant virus.

Hsu KH, Crowe JE, Lubeck MD, Davis AR, Hung PP, Chanock RM, Murphy BR
Vaccine. 1995 13 (5): 509-15

PMID: 7543716 · DOI:10.1016/0264-410x(94)00002-5

MeSH Terms (20)

Animals Azacitidine Carcinoma, Squamous Cell Chlorocebus aethiops Female Fluorouracil Male Mice Mice, Inbred BALB C Mutagenesis Pan troglodytes Phenotype Respiratory Syncytial Virus, Human Respiratory Syncytial Virus Infections Temperature Tumor Cells, Cultured Vaccines, Attenuated Vero Cells Viral Vaccines Virus Replication

Connections (1)

This publication is referenced by other Labnodes entities: